Obesity Clinical Trials in Chicago

Showing 1-20 of 238 trials

A Trial to Assess Full-fat or Low-fat Dairy Foods on Insulin Sensitivity, RBC FA's and Other Markers of Metabolic Health

NCT04999462

The objectives of this trial are to assess the effects of adding 2 servings/d of either full-fat or low-fat fermented dairy products to the diet, as a replacement for non-dairy foods with macronutrient composition similar to the low-fat fermented dairy condition, on insulin sensitivity, erythrocyte fatty acid profile and other cardiometabolic health markers in metabolically at-risk adults.

Overweight and ObesityElevated Triglycerides

Midwest Center for Metabolic and Cardiovascular Research110 participantsStarted Sep 2021

Miami Gardens, Florida, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +1 more locations

COMPLETEDPhase 22.2 miles

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06230523

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with LY3841136 compared with placebo in adult participants with obesity or overweight. The study will last about 64 weeks and may include up to 17 visits.

ObesityOverweight

Eli Lilly and Company263 participantsStarted Feb 2024

Chandler, Arizona, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +40 more locations

A Trial to Assess Full-fat or Low-fat Dairy Foods on Insulin Sensitivity, RBC FA's and Other Markers of Metabolic Health

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

Obesity Trials in Other Cities

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss

Project VIBE: Virtual Intervention for Binge Eating in Adolescents

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

Dissemination and Implementation of the Bright Bodies Intervention for Childhood Obesity

Other Conditions in Chicago